For example, the lncRNA prostate cancer antigen 3 (PCA3) has been approved by the U.S. Food and Drug Administration as a diagnostic biomarker for prostate cancer and is detectable in urine extracellular vesicles [15]. This evidence concerns the gene PCA3 and Familial prostate cancer.